The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Multicenter phase II study of neoadjuvant chemotherapy consisted with S-1 and oxaliplatin followed by gastrectomy for locally advanced gastric cancer.
 
Yoshihiro Okita
No Relationships to Disclose
 
Hironaga Satake
No Relationships to Disclose
 
Hiroyuki Okuyama
No Relationships to Disclose
 
Masato Kondo
No Relationships to Disclose
 
Akira Miki
No Relationships to Disclose
 
Takanori Watanabe
No Relationships to Disclose
 
Yukimasa Hatachi
No Relationships to Disclose
 
Masahito Kotaka
No Relationships to Disclose
 
Shigeyoshi Iwamoto
No Relationships to Disclose
 
Takeshi Kato
No Relationships to Disclose
 
Akihito Tsuji
Honoraria - Chugai Pharma; Daiichi Sankyo; Merck Serono; Taiho Pharmaceutical